Sign in

NCT04432883Recruiting

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

Targeted Transcranial Direct Current Stimulation to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia

Source: ClinicalTrials.gov · Last updated 22 May 2026

Brief summary (registry, in English)

62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
3 Dec 2019
Start date
18 Oct 2022
Primary completion date
26 Mar 2027
Lead sponsor
University of New Mexico
Diseases
Stroke
NCT number
NCT04432883

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 18 Oct 2022 to the primary completion date, 26 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • comorbid neurological disease.
  • significant mood disorder.

Other

  • damage to the anterior right hemisphere.
  • substance/alcohol dependence or abuse within the past year
  • presence of any implanted electrical device or contraindications to tDCS or MRI
  • recent medical instability (within 4 weeks)
  • pregnancy

Who the study is looking for

  • aged 25-85
  • must be greater than 6 months post-stroke
  • must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse production
  • must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage
  • must be stimulable for naming

Age in the registry: 25 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of New Mexico Center for Brain Recovery and Repair
Coordinator of this site? Confirm its status
AlbuquerqueUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.